bpc-157 fda approval status human use Recommends Expanded Peptide Availability BPC-157 FDA Approval Status: Is

If you have a question that isn't here, our team will answer in under an hour

After that it slowly disappeared because it became more and more difficult to obtain radioactive B12 suitable for human use, and at the same time less and less acceptable to use radioactive B12 in a diagnostic test

Common Mild Side Effects Short-term redness or slight irritation at the injection site Light water retention, especially during the initial weeks Increased appetite Mild headaches (rare and usually transient) Temporary fatigue or lightheadedness immediately after injection Who Should Avoid This Therapy People with an active cancer diagnosis or history of cancer, as GH secretagogues increase cellular replication rates Pregnant or breastfeeding individuals should avoid this therapy due to insufficient safety data on its effects during these stages

It is often considered by active adults and patients interested in supporting recovery and mobility